Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies
Status:
Terminated
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the maximally tolerated dose (MTD) and Phase 2
recommended dose of satraplatin when administered in combination with capecitabine in
patients with advanced solid malignancies.